Managing Infliximab Reinduction After temporary Discontinuation of Drug
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Inflammatory Bowel Disease
-
Age: Between 0 - 100 Years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Subjects who are at least 18 years old and able to provide informed consent or subjects younger than 18 years of age who assent and who have a parent or guardian who is willing to consent on the subject’s behalf
- Subjects with history of IBD
- Subjects with history of stable clinical response to prior IFX induction and regular maintenance dosing
- Subjects who were on stable dose of infliximab for at least 3 infusions at regular maintenance intervals
- Subjects with Infliximab drug holiday resulting in missing at least 2 maintenance doses
You may not be eligible for this study if the following are true:
-
- Subjects unwilling to provide informed consent
- Subjects with isolated perianal disease
- Subjects with prior history of serious infusion reaction to IFX
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.